Hepatitis C virus relies on lipoproteins for its life cycle

被引:0
作者
Germana Grassi [1 ]
Giorgia Di Caprio [1 ,2 ]
Gian Maria Fimia [1 ,3 ]
Giuseppe Ippolito [1 ]
Marco Tripodi [1 ,2 ]
Tonino Alonzi [1 ]
机构
[1] National Institute for Infectious Diseases “L. Spallanzani” IRCCS
[2] Department of Cellular Biotechnologies and Hematology,Pasteur Institute-Cenci Bolognetti Foundation,Sapienza University of Rome
[3] Department of Biological and Environmental Sciences and Technologies (Di STe BA),University of Salento
关键词
Apolipoproteins; Hepatitis C virus; Lipid metabolism; Lipoproteins; Review;
D O I
暂无
中图分类号
R373.21 [];
学科分类号
100103 ; 100705 ;
摘要
Hepatitis C virus(HCV) infects over 150 million people worldwide. In most cases, HCV infection becomes chronic causing liver disease ranging from fibrosis to cirrhosis and hepatocellular carcinoma. Viral persistence and pathogenesis are due to the ability of HCV to deregulate specific host processes, mainly lipid metabolism and innate immunity. In particular, HCV exploits the lipoprotein machineries for almost all steps of its life cycle. The aim of this review is to summarize current knowledge concerning the interplay between HCV and lipoprotein metabolism. We discuss the role played by members of lipoproteins in HCV entry, replication and virion production.
引用
收藏
页码:1953 / 1965
页数:13
相关论文
共 41 条
[1]  
Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization[J]. Koen Vercauteren,Ahmed Atef Mesalam,Geert Leroux-Roels,Philip Meuleman.World Journal of Gastroenterology. 2014(43)
[2]   Hepatitis C virus in the new era:Perspectives in epidemiology,prevention,diagnostics and predictors of response to therapy [J].
Filippo Ansaldi ;
Andrea Orsi ;
Laura Sticchi ;
Bianca Bruzzone ;
Giancarlo Icardi .
World Journal of Gastroenterology, 2014, (29) :9633-9652
[3]  
Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection[J] . Jean‐Michel Pawlotsky,Robert Flisiak,Shiv K. Sarin,Jens Rasenack,Teerha Piratvisuth,Wan‐Long Chuang,Cheng‐Yuan Peng,Graham R. Foster,Samir Shah,Heiner Wedemeyer,Christophe Hézode,Wei Zhang,Kelly A. Wong,Bin Li,Claudio Avila,Nikolai V. Naoumov.Hepatology . 2015 (4)
[4]   Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy [J].
Sultanik, Philippe ;
Mallet, Vincent ;
Lagaye, Sylvie ;
Casrouge, Armanda ;
Dorival, Celine ;
Barthe, Yoann ;
Fontaine, Helene ;
Hezode, Christophe ;
Mottez, Estelle ;
Bronowicki, Jean-Pierre ;
Carrat, Fabrice ;
Theodorou, Ioannis ;
Abel, Laurent ;
Gayat, Etienne ;
Fontanet, Arnaud ;
Pol, Stanislas ;
Albert, Matthew L. .
LIVER INTERNATIONAL, 2015, 35 (07) :1833-1844
[5]  
Hepatitis C virus and lipid droplets: finding a niche[J] . Ana Filipe,John McLauchlan.Trends in Molecular Medicine . 2015 (1)
[6]   Amphipathic α-Helices in Apolipoproteins Are Crucial to the Formation of Infectious Hepatitis C Virus Particles [J].
Fukuhara, Takasuke ;
Wada, Masami ;
Nakamura, Shota ;
Ono, Chikako ;
Shiokawa, Mai ;
Yamamoto, Satomi ;
Motomura, Takashi ;
Okamoto, Toru ;
Okuzaki, Daisuke ;
Yamamoto, Masahiro ;
Saito, Izumu ;
Wakita, Takaji ;
Koike, Kazuhiko ;
Matsuura, Yoshiharu .
PLOS PATHOGENS, 2014, 10 (12)
[7]  
Phosphatidylinositol 4,5-bisphosphate is an HCV NS5A Ligand and Mediates Replication of the Viral Genome[J] . Nam-Joon Cho,Choongho Lee,Phillip S. Pang,Edward A. Pham,Benjamin Fram,Khanh Nguyen,Anming Xiong,Ella H. Sklan,Menashe Elazar,Elif S. Koytak,Caroline Kersten,Kay K. Kanazawa,Curtis W. Frank,Jeffrey S. Glenn.Gastroenterology . 2014
[8]  
Virology and cell biology of the hepatitis C virus life cycle – An update[J] . Jean Dubuisson,Fran?ois-Lo?c Cosset.Journal of Hepatology . 2014 (1)
[9]  
Innate and adaptive immune responses in HCV infections[J] . Markus H. Heim,Robert Thimme.Journal of Hepatology . 2014 (1)
[10]  
Natural history of hepatitis C[J] . Rachel H. Westbrook,Geoffrey Dusheiko.Journal of Hepatology . 2014 (1)